Dire shortage of BCG impacts treatment of bladder cancer patients
Leading Australian urologist Professor Dickon Hayne has been one of the many health professionals happy to take part in the…
ASCO 2020: Pembrolizumab plus chemotherapy demonstrated improvement in PFS for patients with metastatic triple-negative breast cancer
Merck has announced positive results from the Phase 3 KEYNOTE-355 trial investigating pembrolizumab in combination with chemotherapy as first-line treatment in…
WE CAN HELP CONNECT YOU
Improving access to essential cancer care for regional and rural patients
An alliance of the four leading bodies representing the radiation therapy sector has today outlined key requirements to ensure Australians…
Thousands of lives could be lost to delays in cancer surgery during Covid-19 pandemic
Delays to cancer surgery and other treatment caused by the Covid-19 crisis could result in thousands of additional deaths linked…
POPULAR
New cancer immunotherapy targeting myeloid cells slows tumour growth
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumour growth were discovered by a team…
Recent Videos
-
Injected Vitamin C Boosts Power of Cancer Immunotherapy in Mice
-
Amplifying others’ voices: meet childhood cancer researcher Claire Wakefield
-
-
ASCO GU 2019 VIDEO: Genitourinary Cancers Symposium Presscast
-
Nobel Prize awarded “for discovery of cancer therapy by inhibition of negative immune regulation”
-
-
Jury finds Monsanto liable in the first Roundup cancer trial – here’s what could happen next
-
Killer immunotherapy—fighting cancer with genetic engineering
-
-
Dire shortage of BCG impacts treatment of bladder cancer patients
Leading Australian urologist Professor Dickon Hayne has been one of the many health professionals happy to take part in the…
